Skip to main content

Table 4 Mutations selected on ARV therapy.

From: Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

Patient

ARV drug regimens

Mutations selected in the PR

Mutations selected in the RT

Corresponding line in table 2

A

d4T-3TC-NFV

V62A, V71I, L99F

M184V

14

 

d4T-ABC-LPV/r

+ S43I, K45R, V47A, I89V

+ I10V, K35T, K82R, Y115F, Q151M

3

B

AZT-3TC-ABC

 

M184V

20

 

d4T-3TC-ABC-TDF

 

+ A62V, K65R, V111I

17

C

AZT-3TC-NVP

 

Q151M, M184V

23

 

ddI-TDF-ABC

 

+ K65R, N69T, V111I, D218E

18

 

3TC-ABC-TDF

 

+ I90V, S215T

21

D

d4T-3TC-NFV

T56A, V62M, V71I

M184V

11

E

d4T-3TC-NFV

V71I/T (*)

 

5

F

3TC-ABC-FPV/r

I54M, I89V, L90M

M184V

27

G

AZT-3TC-ABC

 

K65R, N69S, V83I, I90V, V111I, M184I/V, F214L, Q151M, Y115F

16

H

AZT-3TC-ABC

 

M184V

22

 

TDF-FTC-ATV/r

L90M

 

6

I

AZT-3TC-ABC

 

M184V, K70N, K35R, K64R, K82R, Q151M

19